Cargando…

Long non-coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR-675

Sorafenib is the first-line treatment for advanced hepatocellular carcinoma (HCC). Since many HCC patients experience drug resistance, there is an urgent need to discover more effective therapeutic strategies to overcome drug resistance. Long non-coding RNAs (lncRNAs) play an important role in tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yongzi, Liu, Yanhui, Li, Zhenrong, Li, Hao, Li, Xiqing, Yan, Lei, Mao, Jiayan, Shen, Jian, Chen, Wei, Xue, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251775/ https://www.ncbi.nlm.nih.gov/pubmed/32627034 http://dx.doi.org/10.3892/or.2020.7608

Ejemplares similares

miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer
por: Li, Haiyan, et al.
Publicado: (2015)

Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675
por: Shi, Yan, et al.
Publicado: (2014)

The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism
por: De Martino, Marco, et al.
Publicado: (2017)

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Turato, Cristian, et al.
Publicado: (2019)

Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin
por: Wang, Ran, et al.
Publicado: (2018)

Diagnostic and Prognostic Significance of miR-675-3p in Patients With Atherosclerosis
por: Wang, Shuangquan, et al.
Publicado: (2021)

Golgi phosphoprotein 3 promotes angiogenesis and sorafenib resistance in hepatocellular carcinoma via upregulating exosomal miR-494-3p
por: Gao, Ying, et al.
Publicado: (2022)

The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration
por: Dey, Bijan K., et al.
Publicado: (2014)

miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch Repair
por: Lu, Yanan, et al.
Publicado: (2018)

Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
por: Salvi, Alessandro, et al.
Publicado: (2013)

Bioinformatics Analysis Reveals the Biomarker Value and Potential Mechanism of miR-675-3p in Gastric Cancer
por: Chen, Ruyi, et al.
Publicado: (2022)

miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2021)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

The long non-coding RNA LIMT inhibits metastasis of hepatocellular carcinoma and is suppressed by EGF signaling
por: Hu, Yu, et al.
Publicado: (2022)

Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2
por: Wang, Guanghui, et al.
Publicado: (2019)

miR-675 promotes colorectal cancer cell growth dependent on tumor suppressor DMTF1
por: Yang, Xueliang, et al.
Publicado: (2019)

Decreased expression of H19/miR-675 ameliorates muscle atrophy by regulating the IGF1R/Akt/FoxO signaling pathway
por: Zhang, He, et al.
Publicado: (2023)

cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence
por: Ruan, YeLing, et al.
Publicado: (2023)

miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2
por: Zhou, Yan-Wu, et al.
Publicado: (2016)

Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy
por: Wang, Chen, et al.
Publicado: (2020)

Targeted point mutations of the m(6)A modification in miR675 using RNA-guided base editing induce cell apoptosis
por: Hao, Jindong, et al.
Publicado: (2020)

The kynurenine derivative 3-HAA sensitizes hepatocellular carcinoma to sorafenib by upregulating phosphatases
por: Gan, Guifang, et al.
Publicado: (2021)

Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma
por: Zhao, Cai-Chou, et al.
Publicado: (2021)

lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy
por: Li, Xiangquan, et al.
Publicado: (2016)

LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis
por: Li, Jun, et al.
Publicado: (2022)

H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b
por: Vennin, Constance, et al.
Publicado: (2015)

Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30
por: Guo, Zhigui, et al.
Publicado: (2016)

Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma
por: Zhou, Bei, et al.
Publicado: (2021)

MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells
por: Costa, Viviana, et al.
Publicado: (2017)

MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7
por: Feng, Xiaoning, et al.
Publicado: (2022)

miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
por: Tan, Wenliang, et al.
Publicado: (2021)

miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression
por: Chen, Xianqing, et al.
Publicado: (2019)

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
por: Hu, Xinyao, et al.
Publicado: (2021)

miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation
por: Li, Li, et al.
Publicado: (2022)

H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation
por: Liu, Changkun, et al.
Publicado: (2015)

Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma
por: Guan, Guo-fang, et al.
Publicado: (2016)

Structural Modifications and Novel Protein-Binding Sites in Pre-miR-675—Explaining Its Regulatory Mechanism in Carcinogenesis
por: Dey, Abhishek
Publicado: (2023)

MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Hirao, Akihiro, et al.
Publicado: (2021)

MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
por: He, Changjun, et al.
Publicado: (2015)

Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma
por: Stefanovic, Milica, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1pjm2r41h8lj5mdk9odpvsi75g